Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00780507 · ClinicalTrials.gov registry record
Fecal Biomarker Study for Patients With Ulcerative Colitis
A clinical trial of Ulcerative Colitis, sponsored by Warner Chilcott.
- Completed
- Registry status
- 89
- Enrollment target
- 20
- Study locations
NCT00780507: Completed study of Ulcerative Colitis, sponsored by Warner Chilcott.
NCT00780507 is a study of Ulcerative Colitis that has completed, run by Warner Chilcott. The registered enrollment target is 89 participants, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (96% lower). The trial reports 20 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00780507, a study of Ulcerative Colitis, has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- 89 participants
- Enrollment target
- 20
- Study locations
Study Summary
The present study will analyze fecal levels of FC and FL in UC patients who relapse (flare) while on a QD or a BID Asacol treatment regimen and compare those levels to levels of FC and FL in UC patients who do not relapse (flare).
Conditions Studied
Study Locations (20)
California
- Research Facility - Anaheim
- Research Facility - Folsom
- Research Facility - Los Angeles
- Research Facility - Merced
- Research Facility - San Diego
- Research Facility - Upland
Florida
- Research Facility - Fort Lauderdale
- Research Facility - New Port Richey
- Research Facility - Palm Harbor
- Research Facility - Tampa
- Research Facility - Zephyrhills
Georgia
- Research Facility - Decatur
- Research Facility - Marietta
- Research Facility - Newnan
Illinois
- Research Facility - Arlington Heights
- Research Facility - Oak Lawn
- Research Facility - Urbana
Arkansas
- Research Facility - Lowell
Colorado
- Research Facility - Lafayette
Connecticut
- Research Facility - Torrington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2007-08 |
| Est. Completion | 2009-07 |
What the finished NCT00780507 record still lists
NCT00780507 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Ulcerative Colitis appearing as the primary indexed condition, and to 0 interventions.
NCT00780507 names 20 study sites across 7 states, led by California, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT00780507 about?
NCT00780507 is a clinical study titled "Fecal Biomarker Study for Patients With Ulcerative Colitis". The present study will analyze fecal levels of FC and FL in UC patients who relapse (flare) while on a QD or a BID Asacol treatment regimen and compare those levels to levels of FC and FL in UC patients who do not relapse (flare).
What is the current status of trial NCT00780507?
This trial is currently completed. The enrollment target is 89 participants. The study started on 2007-08. Estimated completion is 2009-07.
What conditions does trial NCT00780507 study?
This clinical trial studies the following conditions: Ulcerative Colitis.
Who is sponsoring clinical trial NCT00780507?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00780507 being conducted?
This trial has 20 study locations across Arkansas, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00780507's enrollment target sits among peer trials
89 70th of 122 higher than 53 of 122 other Ulcerative Colitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ulcerative Colitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
RECRUITING · Phase 2
-
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
RECRUITING
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
RECRUITING · NA
-
Registry and Biorepository for IBD in Central Texas
RECRUITING
-
Nicotinamide Riboside in Ulcerative Colitis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia